Drug Profile

JTT 851

Alternative Names: JTT-851

Latest Information Update: 10 Feb 2017

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator Japan Tobacco
Class Antihyperglycaemics
Mechanism of Action FFAR1 protein stimulants; G protein-coupled receptor agonists

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity Yes

06 Feb 2017 Discontinued - Phase-II for Type-2 diabetes mellitus in Japan (PO) (Japan Tobacco pipeline, February 2017)
06 Feb 2017 Discontinued - Phase-II for Type-2 diabetes mellitus in USA (PO) (Japan Tobacco communication, February 2017)
19 Aug 2015 Phase-II development is ongoing in USA and Japan

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com